Published in Cell Mol Biol (Noisy-le-grand) on February 25, 2010
Marine n-3 fatty acids, wine intake, and heart rate variability in patients referred for coronary angiography. Circulation (2001) 1.61
A difficult conversation? The views and experiences of parents and professionals on the consent process for perinatal postmortem after stillbirth. BJOG (2012) 1.58
Secondary medical prevention among Danish patients hospitalised with either peripheral arterial disease or myocardial infarction. Eur J Vasc Endovasc Surg (2007) 1.58
Alpha-linolenic acid and heart rate variability. Nutr Metab Cardiovasc Dis (2000) 1.40
Effect of fish oil on heart rate variability in survivors of myocardial infarction: a double blind randomised controlled trial. BMJ (1996) 1.22
The effect of N-6 and N-3 polyunsaturated fatty acids on hemostasis, blood lipids and blood pressure. Thromb Haemost (1983) 1.14
C-reactive protein, dietary n-3 fatty acids, and the extent of coronary artery disease. Am J Cardiol (2001) 1.10
Heart rate variability and fatty acid content of blood cell membranes: a dose-response study with n-3 fatty acids. Am J Clin Nutr (1999) 1.07
Bioavailability of marine n-3 fatty acid formulations. Prostaglandins Leukot Essent Fatty Acids (2010) 1.07
Modified Mediterranean diet and survival after myocardial infarction: the EPIC-Elderly study. Eur J Epidemiol (2007) 1.06
Effects of trans- and n-3 unsaturated fatty acids on cardiovascular risk markers in healthy males. An 8 weeks dietary intervention study. Eur J Clin Nutr (2004) 1.01
NT-pro-BNP is an independent predictor of mortality in patients with end-stage renal disease. Clin Nephrol (2009) 0.96
n-3 polyunsaturated fatty acids and coronary thrombosis. Lipids (2001) 0.93
Heart rate variability and n-3 polyunsaturated fatty acids in patients with diabetes mellitus. J Intern Med (2001) 0.92
The effects of dietary supplementation with n-3 polyunsaturated fatty acids in patients with rheumatoid arthritis: a randomized, double blind trial. Eur J Clin Invest (1992) 0.91
[n-3 polyunsaturated fatty acids, heart rate variability and ventricular arrhythmias in post-AMI-patients. A clinical controlled trial]. Ugeskr Laeger (1997) 0.89
Randomized clinical trial of perioperative omega-3 fatty acid supplements in elective colorectal cancer surgery. Br J Surg (2013) 0.88
Dietary supplementation with n-3 polyunsaturated fatty acids and human platelet function: a review with particular emphasis on implications for cardiovascular disease. J Intern Med Suppl (1989) 0.88
Heart rate variability and plasma lipids in men with and without ischaemic heart disease. Atherosclerosis (1999) 0.87
Marine n-3 fatty acids: basic features and background. Lipids (2001) 0.86
Platelet number and volume during myocardial infarction in relation to infarct size. Acta Med Scand (1986) 0.86
Body composition and body fat distribution in relation to later risk of acute myocardial infarction: a Danish follow-up study. Int J Obes (Lond) (2011) 0.86
Fish consumption, n-3 fatty acids in cell membranes, and heart rate variability in survivors of myocardial infarction with left ventricular dysfunction. Am J Cardiol (1997) 0.86
Soluble adhesion molecules in healthy subjects: a dose-response study using n-3 fatty acids. Nutr Metab Cardiovasc Dis (2004) 0.83
n-3 fatty acids and renal diseases. Am J Kidney Dis (1994) 0.83
Myopericarditis with cardiac tamponade caused by Neisseria meningitidis serogroup W135. Eur J Clin Microbiol Infect Dis (1988) 0.81
Dietary fibre intake and ischaemic heart disease mortality: the European Prospective Investigation into Cancer and Nutrition-Heart study. Eur J Clin Nutr (2012) 0.81
The effect of n-3 polyunsaturated fatty acids on leukotriene B₄ and leukotriene B₅ production from stimulated neutrophil granulocytes in patients with chronic kidney disease. Prostaglandins Leukot Essent Fatty Acids (2011) 0.80
Plasma concentration levels of apolipoprotein A-I, apolipoprotein B and lipoprotein (a) in Greenland Inuit (Eskimos). J Intern Med (1992) 0.79
Effects of marine n-3 fatty acids on circulating levels of soluble adhesion molecules in patients with chronic heart failure. Cell Mol Biol (Noisy-le-grand) (2010) 0.79
Normal lipoprotein(a) concentrations and apolipoprotein(a) isoforms in patients with insulin-dependent diabetes mellitus. Eur J Clin Invest (1992) 0.79
n-3 fatty acids and the risk of sudden cardiac death. Lipids (2001) 0.79
Heart rate variability and n-3 fatty acids in patients with chronic renal failure--a pilot study. Clin Nephrol (1998) 0.79
Testing aspirin resistance using the Platelet Function Analyzer-100: some methodological caveats and considerations. J Thromb Haemost (2007) 0.78
The acute effects of a single very high dose of n-3 fatty acids on plasma lipids and lipoproteins in healthy subjects. Lipids (1994) 0.78
The effect of low-dose marine n-3 fatty acids on the biosynthesis of pro-inflammatory 5-lipoxygenase pathway metabolites in overweight subjects: a randomized controlled trial. Prostaglandins Leukot Essent Fatty Acids (2012) 0.78
The effect of n-3 fatty acids on neutrophil chemiluminescence. Scand J Clin Lab Invest (1995) 0.77
The effect of N-3 fatty acids on plasma myeloperoxidase levels in healthy adults. Cell Mol Biol (Noisy-le-grand) (2010) 0.77
n-3 fatty acids and cardiovascular disease--observations generated by studies in Greenland Eskimos. Wien Klin Wochenschr (1989) 0.77
N-3 fatty acids and cardiac autonomic function in humans. Cell Mol Biol (Noisy-le-grand) (2010) 0.77
Plasma half-life of DDAVP in uraemic patients. Acta Pharmacol Toxicol (Copenh) (1986) 0.77
Fish oil in angina pectoris. Atherosclerosis (1987) 0.77
No effect of high-dose atorvastatin on leukotriene B₄ formation from neutrophils in patients treated with coronary bypass surgery: a randomized placebo-controlled double-blinded trial with a crossover design. Prostaglandins Leukot Essent Fatty Acids (2012) 0.77
Fatty acid composition of the internal mammary artery in relation to dietary intake of marine n-3 polyunsaturated fatty acids and association with flow-mediated vasodilation. Cell Mol Biol (Noisy-le-grand) (2010) 0.77
n-3 fatty acids and the risk of sudden cardiac death assessed by 24-hour heart rate variability. Lipids (1999) 0.76
N-3 fatty acids and cardiac function after myocardial infarction in Denmark. Int J Circumpolar Health (2001) 0.76
Fish oil and ischaemic heart disease. Br Heart J (1993) 0.76
Serum myoglobin measured by latex agglutination: rapid test for exclusion of acute myocardial infarction. Am Heart J (1986) 0.76
n-3 fatty acids do not decrease plasma endothelin levels in healthy individuals. Scand J Clin Lab Invest (1997) 0.76
[Fish oils and rheumatoid arthritis. A randomized and double-blind study]. Ugeskr Laeger (1994) 0.76
Serum concentrations of matrix metalloproteinase-9, tissue inhibitor of matrix metalloproteinase-1 and alpha2-macroglobulin in healthy subjects after supplementation with different doses of marine n-3 fatty acids. Cell Mol Biol (Noisy-le-grand) (2010) 0.76
The influence of dietary n-3 fatty acids on plasma lipids and lipoproteins. Ann N Y Acad Sci (1993) 0.75
Homocysteine in Greenland Inuits. Thromb Res (1997) 0.75
The future--threat or promise. Bedside Nurse (1968) 0.75
1-Deamino-8-D-arginine vasopressin lowers protein C activity in uremics. Nephron (1989) 0.75
Monoclonal gammopathy in general practice. Diagnostic value of typing and quantitation of immunoglobulins. Scand J Prim Health Care (1985) 0.75
What's new in practical nursing education. Am J Pract Nurs (1967) 0.75
Haemostatic aspects of renal transplantation. Scand J Urol Nephrol (1988) 0.75
[Nuchal rigidity in hyperosmolar, non-ketotic diabetic coma]. Tidsskr Nor Laegeforen (1988) 0.75
Diagnostic value of the concentration of M-component in initial classification of monoclonal gammopathy. Scand J Haematol (1986) 0.75
Tuberous sclerosis. CT findings versus clinical state. Rofo (1987) 0.75
[Arterial blood gases in acute myocardial infarction]. Ugeskr Laeger (1986) 0.75
[Primary amyloidosis]. Ugeskr Laeger (1982) 0.75
[Thrombotic thrombocytopenic purpura]. Ugeskr Laeger (1982) 0.75
Differences in apolipoprotein (a) polymorphism in west Greenland Eskimos and Caucasian Danes. Hum Genet (1992) 0.75
n-3 polyunsaturated fatty acids: update 1995. Eur J Clin Invest (1995) 0.75
Editorial--health career ladders. Am J Pract Nurs (1967) 0.75
[Fish oils and rheumatoid arthritis]. Ugeskr Laeger (1994) 0.75
Intravenous acetylsalicylic acid--dose-related effects on platelet function and fibrinolysis in healthy males. Thromb Haemost (1992) 0.75
Constructive leadership. Bedside Nurse (1968) 0.75
The occurrence of malignant disease in adult nephrotic syndrome. J Intern Med (1989) 0.75
[Primary pulmonary hypertension]. Ugeskr Laeger (1986) 0.75
[Microangiopathic hemolytic anemia associated with thrombocytopenia]. Ugeskr Laeger (1982) 0.75
[The diagnostic significance of finding a M-component in serum]. Ugeskr Laeger (1986) 0.75
Perforated peptic ulcer--a complication in acute salicylate intoxication. Acta Med Scand (1987) 0.75
[Hypokalemia and arrhythmia in acute myocardial infarction]. Ugeskr Laeger (1986) 0.75
The effect of low-dose supplementation with n-3 polyunsaturated fatty acids on some risk markers of coronary heart disease. Scand J Clin Lab Invest (1993) 0.75
More schools, more LPN's, more duties. Mod Hosp (1967) 0.75
The acute effect of a single very high dose of N-3 fatty acids on coagulation and fibrinolysis. Thromb Res (1992) 0.75
Pneumatosis intestinalis in a patient on chronic haemodialysis treatment. Nephrol Dial Transplant (1989) 0.75
The effect of n-3 fatty acids on leukotriene formation from neutrophils in patients on hemodialysis. Lipids (1999) 0.75
Interobserver variation in interpretation of electrocardiographic signs of atrial infarction. Clin Cardiol (1993) 0.75
Verapamil does not alter platelet function in patients with recent myocardial infarction. Thromb Res (1983) 0.75
[Arrhythmias during the first 24 hours of hospitalization for the first episode of acute myocardial infarction]. Ugeskr Laeger (1985) 0.75
Exercise decreases the platelet sensitivity to prostacyclin in patients with angina pectoris. Prostaglandins Leukot Med (1985) 0.75
Editorial--shortage of nurses. Am J Pract Nurs (1967) 0.75
Monoclonal gammopathy in general practice. Associated clinical conditions. Scand J Prim Health Care (1985) 0.75
[Severe cardiac insufficiency caused by myelomatosis not recognized previously]. Ugeskr Laeger (1985) 0.75
Detection rate and clinical significance of monoclonal gammopathy in different age groups in the population of Northern Jutland, Denmark. Dan Med Bull (1985) 0.75